References
- Andersen MH, Pedersen LØ, Capeller B, Bröcker E-B, Becker JB, thor Straten P (2001)
Spontaneous cytotoxic T-cell responses against Survivin-derived MHC class I-restricted T-cell epitopes in Situ as well as ex vivo in cancer patients
Cancer Res, Aug, 61,5964-68 - Schrama D, Pedersen LØ, Keikavoussi P, Andersen MH, Straten Pt, Bröcker E-B, Kämpgen E Becker JC , (2002)
Aggregation of Antigen-Specific T Cells at the Inoculation Site of Mature Dendritic Cells
J Invest Dermatol 119:1443-48 - Schrama D, Eggert AAO, Bröcker E-B, Pedersen LØ, Straten Pt, Becker JC (2003)
Immunological consequences of the sentinel lymph-node biopsy-lessons from a melanoma patient
Lancet Oncol 4:446-47 - Andersen MH, Reker S, Becker JC, Straten Pt (2004)
The Melanoma Inhibitor of Apoptosis Protein: A Target for Spontaneous Cytotoxic T Cell Response
J Invest Dermatol 122:392-399 - Berger TG, Haendle I, Schrama D, Lüftl M, Bauer N, Pedersen LØ, Schuler-Thurner B, Hohenberger W, thor Straten P, Schuler G, Becker JC (2004)
Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocytes-derived dendritic cells
Int J Cancer 111,229-37 - Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LØ, Rath JC, Böck M, Bröcker E-B, thor Straten P, Kämpgen E, Becker JC (2005)
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen surviving
Vaccine Jan4;23(7)884-9 - Thor Straten P, Dahl C, Schrama D, Pedersen LØ, Andersen MH, Seremet T, Bröcker E-B, Guldberg P, Becker JC (2006)
Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes
Cancer Immunol Immunother May;4(5)399-409 - Storm P, Bartholdy C, Sørensen MR, Christensen JP, Thomsen AR (2006)
Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite Impaired cytokine production
J Virol Feb 80(3)1222-1230 - Hadrup SR, Strindhall J, Køllgaard T, Johansson B, Pawelec G, thor Straten P, Wikby A (2006)
Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional CMV specific T cells in the very elderly.
J Immunol (Feb) 176(4)1645-53 - Batard P, Peterson DA, Devevre E, Guillaume P, Cerottini J-C, Rimoldi D, Speiser DE, Winther L, Romero P (2006)
Dextramers: New generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8 T cells.
J Immunol Methods March 20;310(1-2)136-48 - Christensen JE, de Lemos C, Moos T, Christensen JP and Thomsen AR (2006)
CXCL10 is the key ligand for CXCR3 on CD8+ effector T-cells involved in immune surveillance of the LCMV-infected CNS.
J Immunol Apr 176(7):4235-43 - Hadrup SR, Gehl J, Sørensen RB, Geertsen P, thor Straten P, Andersen MH (2006)
Persistence of survivin specific T cells for seven years in a malignant melanoma patient during complete remission.
Cancer Biol Ther May 5:5, 480-2 - Sorensen RB, Hadrup SR, Kollgaard T, Svane IM, Thor Straten P, Andersen MH (2006)
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient.
Cancer Immunol Immunother Apr;56(4)527-33 - Poulsen LH, Jacobsen K, Storie I, Jakobsen T, Laursen J (2006)
High-speed quantitation of CMV specific cytotoxic T-cells in whole blood
MASIR Meeting June 2006, Abstract#P74 - Hadrup SR, Braendstrup O, Jacobsen GK, Mortensen S, Pedersen LO, Seremet T, Andersen MH, Becker JC, Straten PT (2006)
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells.
Int J Cancer 2006 Aug 15;119(4):831-8 - Gupta AJ, Leung E, Mi H, Carter V, Anand V, Chatopadhyay, Shenton B, Kirby J, Talbot D (2006)
Assessment of variation in Epstein-Barr virus specific T cells following transplantation using MHC class I-peptide complexes (Abstract)
Transplantation Suppl. Abstract #253 (PO-151) www.wtc2006.org - Svane IM, Pedersen AE, Johnsen HE, Nielsen D, Kamby C, Nikolajsen S, Ottesen S, Zocca M, Johansen JS, Claesson MH (2006)
Dendritic cells loaded with wild-type p53 peptides induce T cell immunity and disease stabilization in patients with advanced breast cancer (Abstract)
J Clin Oncol 24(18Suppl)June, 2577 - Houtenbos I, Westers TM, Dijkhuis A, de Gruijl TD, Ossenkoppele GJ, van de Loosdrecht AA (2007)
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Clin Cancer Res Jan1;13(1)307-15 - Bartholdy C, Kauffmann SO, Christensen JP Thomsen AR (2007)
Agonistic anti CD-40 antibody profoundly suppresses the immune response to infection with lymphocytic chriomeningitis virus.
J Immunol 178:1662-1670 - Holst PJ, Bartholdy C, Stryhn A, Thomsen AR, Christensen JP (2007)
Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens
J Gen Virol 88 (in press) - Holst PJ, Orskov C, Qvortrup K, Christensen JP, Thomsen AR (2007)
CCR5 and CXCR3 are dispensable for liver infiltration, but CCR5 protects against virus-induced T-cell-mediated Hepatic Steatosis
J Virol, Sept 2007, 10101-10112.
Products and support
If you need information concerning Immudex products, have a technical enquiry, or are interested in customer-defined Dextramers and/or collaboration with Immudex, please contact us on Email customer@immudex.com
If you need ordering information, please contact on us Email ordering@immudex.com
